Efficacy and Cautions of Cariprazine in Clinical Practice

This chapter examines the effectiveness of cariprazine versus risperidone in addressing negative symptoms of schizophrenia, based on key findings from a 2017 study. It also addresses potential side effects, concerns over promotional practices, and the implications of cost and FDA approvals in treatment settings.